Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:investigational_drug
gptkb:chemical_compound |
| gptkbp:CASNumber |
2627-69-2
|
| gptkbp:chemicalFormula |
C9H13N5O4
|
| gptkbp:clinicalTrialPhase |
Phase III (as of 2010s)
|
| gptkbp:developedBy |
PeriCor Therapeutics
|
| gptkbp:effect |
increases cellular AMP levels
modulates energy metabolism |
| gptkbp:IUPACName |
5-Amino-1-β-D-ribofuranosylimidazole-4-carboxamide
|
| gptkbp:mechanismOfAction |
activates AMP-activated protein kinase (AMPK)
|
| gptkbp:molecularWeight |
259.23 g/mol
|
| gptkbp:PubChem_CID |
gptkb:CHEMBL123
60961 |
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:synonym |
gptkb:AICAR
AICA ribonucleotide |
| gptkbp:UNII |
6Z5B6HVF6O
|
| gptkbp:used_in_research_for |
gptkb:diabetes
metabolic diseases ischemia |
| gptkbp:bfsParent |
gptkb:AICAR
|
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
Acadesine
|